共 56 条
[31]
Su B(2021)Soluble immune checkpoint-related proteins as predictors of tumor recurrence, survival, and T cell phenotypes in clear cell renal cell carcinoma patients Nat Commun 12 5764-42
[32]
Christensen BR(2019)Coexpression of lymphocyte-activation gene 3 and programmed death ligand-1 in tumor infiltrating immune cells predicts worse outcome in renal cell carcinoma J Immunother Cancer 7 334-9
[33]
Deshpande RA(2022)Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma Int J Immunopathol Pharmacol 36 3946320221125588-9
[34]
Shankar V(2018)A genomic instability-derived risk index predicts clinical outcome and immunotherapy response for clear cell renal cell carcinoma Science 359 801-6
[35]
Acquati F(2021)TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy Bioengineered 12 1642-83
[36]
Krishna C(2017)Comprehensive landscape of immune-checkpoints uncovered in clear cell renal cell carcinoma reveals new and emerging therapeutic targets Immunol Rev 276 112-undefined
[37]
Kim MC(2020)TGFB1 mRNA expression is associated with poor prognosis and specific features of inflammation in ccRCC Cancer Immunol Immunother 69 1237-undefined
[38]
Wang Q(2022)Epigenetic remodelling shapes inflammatory renal cancer and neutrophil-dependent metastasis Virchows Arch 480 635-undefined
[39]
Lee CH(2020)Silencing of the chemokine CXC receptor 4 (CXCR4) hampers cancer progression and increases cisplatin (DDP)-sensitivity in clear cell renal cell carcinoma (ccRCC) Nat Cell Biol 22 465-undefined
[40]
Miao D(2021)Somatic mutation in cancer and normal cells Bioengineered 12 2957-undefined